EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
The EAHP EU Monitor is a regular round up of news relevant to hospital pharmacy in Europe.
You can subscribe to receive the EAHP EU Monitor by email HERE.
One month left to submit your abstract to the 22nd Congress of the EAHP!Readers of the EAHP EU Monitor are kindly reminded that abstracts for the 22nd Congress of the EAHP (22-24 March 2017, Cannes) must be submitted by a deadline of close of Sunday 16th October 2016.
A range of information about submitting abstracts is provided on the EAHP website, including:
Abstract submissions from all disciplines of hospital pharmacy and related areas are welcomed, including, but not limited to:
Abstracts must be structured and written in five paragraphs:
Abstracts are limited to not more than 350 words.
The best abstracts/posters, with regards to aspects like originality, scientific quality and practical applicability, will be awarded with 3 prizes amounting to 750 euro, 500 euro and 250 euro.
More information HERE.
The European Commission seeks to recruit new civil society representatives to the Committee for Advanced Therapies (CAT) and the Pediatric Committee (PDCO) of the European Medicines Agency (EMA). Interested hospital pharmacists are encouraged to apply before the respective deadlines of 30 September and 31 October.
The Committee for Advanced Therapies (CAT) is the committee at the European Medicines Agency that is responsible for assessing the quality, safety and efficacy of advanced-therapy medicinal products (ATMPs) and following scientific developments in the field. It is a multidisciplinary committee, gathering together some of the best available experts in Europe.
Two members and two alternate members of the CAT are appointed by the European Commission to represent “clinicians”, a definition of which may be taken to include hospital pharmacists with practice expertise in the field.
More information about how to apply for the CAT vacancies before the 30 September deadline is available HERE.
The Paediatric Committee (PDCO) is the committee at the European Medicines Agency that is responsible for assessing the content of paediatric investigation plans and adopting opinions on them. This includes assessing applications for full or partial waivers and assessing applications for deferrals.
Three members and three alternate members of the PDCO are appointed by the European Commission to represent healthcare professionals.
More information about how to apply for the PDCO vacancies before the 31 October deadline is available HERE.
The International Pharmaceutical Federation (FIP)’s Education Development Team is inviting pharmacists to provide feedback on a new “Global Vision” for the Pharmacy Workforce, as well supporting “Pharmaceutical Workforce Development Goals”. The deadline for responses is Friday 30th September.
It is intended that the final vision and development goals will be agreed at The Global Conference on Pharmacy and Pharmaceutical Sciences Education, taking place on the 7 and 8 November 2016, in Nanjing, China.
Feedback received during the consultation period in advance of the Conference will be used to finesse and refine the final vision and goals.
The Draft Vision Statement is available here. The consultation survey on the Vision Statement is HERE.
The Draft Workforce Development Goals are available here. The consultation survey on the Workforce Development Goals is available HERE.
September’s edition of the European Journal of Hospital Pharmacy includes an editorial on recent regulatory concerns about strong opioids, and original articles on: the impact of pharmacy care upon adherence to cardiovascular medicines; and, antimicrobial consumption in a tertiary children’s hospital in Finland.
The edition also contains a systematic review of approaches for calculating the cost of medication errors, as well as a postscript letter on the efficacy of risperidone for the treatment of delirium.
More HERE.
Tony West, the Project Director for Implementation of the European Statements of Hospital Pharmacy, has been recognised by the Royal Pharmaceutical Society (RPS) with an award for Lifetime Achievement.
The award recognises an individual who has made an outstanding contribution to the pharmacy profession throughout their career by promoting pharmacy, innovation, research and development.
Helen Gordon, Chief Executive of the RPS, described West as a “phenomenal leader and role model in hospital pharmacy both in the UK and Europe”.
“Among his many achievements has been his development of hospital pharmacy services at Guy’s and St Thomas’ (London), which have led the way for other hospital pharmacies,” she added.
Tony West recently retired from his role as chief pharmacist at Guy’s and St Thomas’ NHS Foundation Trust, and also served for many years on the Board of Directors of EAHP as Director of Finance. He recently accepted a position as EAHP’s Project Director for Implementation of the European Statements of Hospital Pharmacy.
EAHP President Joan Peppard remarked: “I am thrilled that Tony has received this richly deserved recognition of a lifetime’s contribution to hospital pharmacy and the patient interest. Tony brings enthusiasm, commitment and a wealth of experience to the practice of pharmacy and its on-going development. We are also delighted that he accepted a new role as EAHP’s Project Director for Implementation of the European Statements of Hospital Pharmacy. It’s a privilege for EAHP and an advantage for patients in European hospitals to continue to benefit from his knowledge and experience in this way.”
